Crossmark

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Crossref DOI link: https://doi.org/10.1186/s12885-017-3525-9

Published Online: 2017-08-10

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oh, Doo-Yi

Jung, Kyungsoo

Song, Ji-Young

Kim, Seokhwi

Shin, Sang

Kwon, Yong-Jun

Oh, Ensel

Park, Woong-Yang

Song, Sang Yong

Choi, Yoon-La
Funding

Funding for this research was provided by:

a Korea Health Technology R&D Project grant from the Korea Health Industry Development Institute (KHIDI) (HI14C3418)

the National Research Foundation of Korea (NRF) (2016R1A2B2012945)